MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 82 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $118,000 | +110.7% | 46,734 | +71.0% | 0.00% | – |
| Q1 2020 | $56,000 | -49.5% | 27,329 | -46.9% | 0.00% | – |
| Q4 2019 | $111,000 | +22.0% | 51,468 | -12.8% | 0.00% | – |
| Q3 2019 | $91,000 | -32.1% | 59,031 | +82.5% | 0.00% | – |
| Q2 2019 | $134,000 | +139.3% | 32,351 | +142.6% | 0.00% | – |
| Q1 2019 | $56,000 | -1.8% | 13,336 | -33.3% | 0.00% | – |
| Q4 2018 | $57,000 | -90.3% | 20,000 | -65.8% | 0.00% | – |
| Q3 2018 | $585,000 | +75.7% | 58,556 | +24.4% | 0.00% | – |
| Q2 2018 | $333,000 | +43.5% | 47,057 | -22.2% | 0.00% | – |
| Q1 2018 | $232,000 | – | 60,501 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,977,453 | $15,194,000 | 8.96% |
| Granite Point Capital Management, L.P. | 2,638,321 | $10,078,000 | 0.98% |
| New Leaf Venture Partners, L.L.C. | 342,550 | $1,309,000 | 0.71% |
| 683 Capital Management, LLC | 1,200,000 | $4,584,000 | 0.40% |
| Virtus ETF Advisers LLC | 80,389 | $307,000 | 0.27% |
| Iguana Healthcare Management, LLC | 100,000 | $382,000 | 0.25% |
| THREE BAYS CAPITAL LP | 944,300 | $3,607,000 | 0.25% |
| Granite Point Capital Management, L.P. | 549,900 | $2,101,000 | 0.20% |
| Cormorant Asset Management, LP | 478,111 | $1,826,000 | 0.14% |
| GMT CAPITAL CORP | 2,533,798 | $9,680,000 | 0.12% |